WO2009104205A8 - Delayed release formulation of chloride channel activator - Google Patents

Delayed release formulation of chloride channel activator Download PDF

Info

Publication number
WO2009104205A8
WO2009104205A8 PCT/IN2009/000117 IN2009000117W WO2009104205A8 WO 2009104205 A8 WO2009104205 A8 WO 2009104205A8 IN 2009000117 W IN2009000117 W IN 2009000117W WO 2009104205 A8 WO2009104205 A8 WO 2009104205A8
Authority
WO
WIPO (PCT)
Prior art keywords
chloride channel
delayed release
channel activator
release formulation
activator
Prior art date
Application number
PCT/IN2009/000117
Other languages
French (fr)
Other versions
WO2009104205A1 (en
Inventor
Abhay Yeshwantrao
Pavankumar Potti
Thommandru Vijaya Kumar
Srirupa Das
Sheetal Kulkarni
Dipak Manohar Patil
Original Assignee
Lupin Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Limited filed Critical Lupin Limited
Publication of WO2009104205A1 publication Critical patent/WO2009104205A1/en
Publication of WO2009104205A8 publication Critical patent/WO2009104205A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Abstract

The present invention relates to the delayed release formulations of Chloride Channel Activator. The preferred Chloride channel activator is lubiprostone.
PCT/IN2009/000117 2008-02-20 2009-02-20 Delayed release formulation of chloride channel activator WO2009104205A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN306KO2008 2008-02-20
IN306/KOL/2008 2008-02-20

Publications (2)

Publication Number Publication Date
WO2009104205A1 WO2009104205A1 (en) 2009-08-27
WO2009104205A8 true WO2009104205A8 (en) 2010-09-10

Family

ID=40786682

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000117 WO2009104205A1 (en) 2008-02-20 2009-02-20 Delayed release formulation of chloride channel activator

Country Status (1)

Country Link
WO (1) WO2009104205A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019221215A1 (en) * 2018-05-18 2019-11-21 ニプロ株式会社 Lubiprostone-containing particulate medicinal composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
DE602004030245D1 (en) * 2003-07-03 2011-01-05 Sucampo Ag PHARMACEUTICAL MAGENTATE-RESISTANT COATED COMPOSITION CONTAINING PROSTAGLANDIN ANALOGUE AS CHLORIDE CHANNEL OPENER

Also Published As

Publication number Publication date
WO2009104205A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
AU2009276339A8 (en) Pyrimidine compounds, compositions and methods of use
IL211541A0 (en) Co-crystal compositions, methods of producing the same and uses thereof
MX341825B (en) Heteroaryl compounds and uses thereof.
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
IL208858A (en) Lipid-containing formulations, methods of selection and preparation of the same and uses thereof
WO2008067219A3 (en) Quinazolinone modulators of tgr5
TN2010000044A1 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
WO2010081036A3 (en) Fluorine containing compounds and methods of use thereof
MX2011014019A (en) Diazahomoadamantane derivatives and methods of use thereof.
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
HK1133642A1 (en) Azaadamantane ester and carbamate derivatives and methods of use thereof
WO2013057013A3 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
WO2010054286A3 (en) Substituted hydroxyphenylamine compounds
EP2557919A4 (en) Stabilized statin formulations
WO2009024374A3 (en) Novel dipolar ionic compounds comprising formulations and the use thereof
WO2010081034A3 (en) Fluorine containing compounds and methods of use thereof
TN2009000510A1 (en) Extended release formulation of nevirapine
WO2010047592A3 (en) Preservation mixture and use thereof
WO2009094457A3 (en) Substituted benzhydrylethers
WO2009146793A3 (en) Active substance combinations having insecticidal and acaricidal properties
WO2010065586A3 (en) Preparation of capecitabine
WO2010007441A3 (en) Phosphopeptides and use of the same
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
WO2011006088A3 (en) Fluorine containing compounds and methods of use thereof
WO2008098143A3 (en) Antimicrobial compounds and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09712070

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 09712070

Country of ref document: EP

Kind code of ref document: A1